Total Payments
$2,463
2024 Payments
$422.03
Companies
31
Transactions
153
Medicare Patients
1,947
Medicare Billing
$226,872
Payment Breakdown by Category
Food & Beverage$2,463 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,463 | 153 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $464.04 | 28 | $0 (2024) |
| Novo Nordisk Inc | $413.91 | 28 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $243.99 | 13 | $0 (2024) |
| Lundbeck LLC | $106.24 | 6 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $102.31 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $98.22 | 6 | $0 (2023) |
| Lilly USA, LLC | $96.75 | 6 | $0 (2024) |
| Mylan Specialty L.P. | $96.51 | 5 | $0 (2024) |
| PFIZER INC. | $92.82 | 6 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $72.63 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $422.03 | 22 | ABBVIE INC. ($159.11) |
| 2023 | $1,366 | 87 | Novo Nordisk Inc ($238.45) |
| 2022 | $570.14 | 37 | Novo Nordisk Inc ($85.42) |
| 2021 | $104.46 | 7 | AbbVie Inc. ($51.16) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Gastroenterology | ||||||
| 03/02/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/27/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Diabetes | ||||||
| 02/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: DIABETES | ||||||
| 02/23/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROLOGY | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/17/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: NEUROSCIENCE | ||||||
| 02/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Inflammation | ||||||
| 02/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: PSYCHIATRY | ||||||
| 01/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Obesity | ||||||
| 01/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Diabetes | ||||||
| 01/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Biological | ||||||
| 01/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: NEUROSCIENCE | ||||||
| 01/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: DIABETES | ||||||
| 12/15/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: PAIN | ||||||
| 12/12/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 550 | 943 | $139,645 | $49,072 |
| 2022 | 12 | 582 | 1,214 | $175,173 | $62,712 |
| 2021 | 5 | 485 | 1,491 | $222,750 | $81,617 |
| 2020 | 4 | 330 | 529 | $83,388 | $33,472 |
Total Patients
1,947
Total Services
4,177
Medicare Billing
$226,872
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 74 | 266 | $33,250 | $11,903 | 35.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 70 | 180 | $29,700 | $11,159 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 139 | 171 | $29,070 | $8,551 | 29.4% |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | Office | 2023 | 45 | 48 | $12,834 | $6,709 | 52.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 79 | $18,960 | $5,359 | 28.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 24 | 31 | $7,378 | $2,727 | 37.0% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Office | 2023 | 21 | 27 | $4,590 | $1,435 | 31.3% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 15 | 16 | $1,296 | $405.63 | 31.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 38 | 48 | $460.00 | $389.20 | 84.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 30 | 42 | $1,932 | $356.85 | 18.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 32 | 35 | $175.00 | $77.00 | 44.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 120 | 524 | $65,500 | $22,404 | 34.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 115 | 275 | $45,375 | $15,155 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 136 | $23,120 | $8,682 | 37.6% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 41 | 44 | $11,440 | $6,152 | 53.8% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 43 | 63 | $14,994 | $5,207 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 35 | $8,400 | $2,869 | 34.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 23 | 23 | $2,645 | $799.14 | 30.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 21 | 40 | $1,200 | $651.27 | 54.3% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Office | 2022 | 12 | 12 | $1,392 | $483.41 | 34.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 19 | $874.00 | $173.75 | 19.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 24 | 25 | $125.00 | $73.68 | 58.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 18 | 18 | $108.00 | $61.42 | 56.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 158 | 862 | $107,750 | $37,725 | 35.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 145 | 418 | $68,970 | $24,463 | 35.5% |
About Ginger Epling, FNP
Ginger Epling, FNP is a Family healthcare provider based in Martinsville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2020. The National Provider Identifier (NPI) number assigned to this provider is 1275151573.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ginger Epling, FNP has received a total of $2,463 in payments from pharmaceutical and medical device companies, with $422.03 received in 2024. These payments were reported across 153 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,463).
As a Medicare-enrolled provider, Epling has provided services to 1,947 Medicare beneficiaries, totaling 4,177 services with total Medicare billing of $226,872. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Martinsville, VA
- Active Since 07/13/2020
- Last Updated 07/13/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1275151573
Products in Payments
- VRAYLAR (Drug) $267.43
- REXULTI (Drug) $224.79
- Ozempic (Drug) $145.28
- Rybelsus (Drug) $118.49
- Wegovy (Drug) $94.82
- JARDIANCE (Drug) $93.28
- BREZTRI (Drug) $86.04
- VYEPTI (Biological) $77.30
- MOUNJARO (Drug) $76.10
- PREVNAR 13 (Biological) $64.53
- VIBERZI (Drug) $64.01
- BELSOMRA (Drug) $62.34
- YUPELRI (Drug) $60.21
- Kerendia (Drug) $57.12
- LINZESS (Drug) $54.24
- Dexcom G6 Transmitter (Medical Supply) $48.37
- CONTRAVE (Drug) $48.20
- QUVIVIQ (Drug) $48.16
- Veozah (Drug) $46.86
- QULIPTA (Drug) $45.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Martinsville
Wendy Gilraine
Family — Payments: $7,377
Family $7,377
Ronikka Hannans, Fnp, FNP
Family — Payments: $5,218
Family $5,218
Brandi Fritsche, Fnp, FNP
Family — Payments: $4,593
Family $4,593
Ms. Susan Weeks, Np, NP
Family — Payments: $4,004
Family $4,004
Ms. Melinda Winikur, Fnp, FNP
Family — Payments: $3,954
Family $3,954
Mrs. Amanda Hundley, Crnp, CRNP
Family — Payments: $3,606
Family $3,606